Advisory Board, in formation
A compliance and content advisory board, built with our founding cohort.
Authoritize is in beta through Q3 2026. We are intentionally not publishing a list of equity-holding "Authoritize physicians" before they exist. The advisory board forms in Q4 2026 and will be recruited primarily from founding-cohort customers whose clinical depth and regulatory instincts are a fit.
What the board does
The advisory board shapes the content engine and the compliance scanner, not individual articles. They help decide which FTC and FDA warning-letter patterns the scanner flags, which clinical evidence the engine weights, and which sub-vertical playbooks the platform supports.
The board does not attest patient-facing articles. Every Authoritize-published article is attested by the customer clinic's own licensed physician, who reviews, revises, and signs each piece before publication. That is the only review path. It is not tier-gated, and there is no "Authoritize physician sign-off" option.
Why the board is not yet seated
The clinicians best suited to shape this product are practicing physicians running the kinds of clinics Authoritize serves. We would rather seat the board after the platform has run live with real founding-cohort customers than ship a stock photo of four "Authoritize MDs" we recruited as a marketing exercise.
If you are a board-certified physician operating in hormone optimization, peptide therapy, DPC, or GLP-1 weight management and are interested in shaping the platform from the founding-cohort side, tell us.
Plain statement of what is real today
Authoritize is currently a two-person team building a platform for physician-led clinics. The advisory board described on this page is in formation, with seats expected to be filled in Q4 2026. Until those seats are filled, no Authoritize-affiliated physician attests article content. Patient-facing content is always attested by the clinic's own licensed physician.